• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pregnancy termination with a high and medium dosage regimen of RU 486.

作者信息

Shoupe D, Mishell D R, Brenner P F, Spitz I M

出版信息

Contraception. 1986 May;33(5):455-61. doi: 10.1016/s0010-7824(86)80004-x.

DOI:10.1016/s0010-7824(86)80004-x
PMID:3757511
Abstract

Sixty healthy pregnant women who wished to terminate their pregnancy and who were no more than 49 days pregnant were treated with one of three different dose regimens of a synthetic progesterone receptor blocker, RU 486. Serum cortisol was measured to determine the antiglucocorticoid effects of this compound. The high dose but shorter treatment regimen (400 mg/day RU 486 X 4 days or 200 mg/day X 4 days) was associated with a high (greater than 80%) rate of side effects, especially nausea, vomiting, weakness and heavy bleeding and a low rate of success (10%). A group of 50 subjects received the medium dose but longer treatment regimen (100 mg/day X 7 days). This group had less side effects (40-60%) and a 72.3% success rate of complete abortion. The AM cortisol values were significantly elevated in all treatment groups but higher in those receiving the high dose. These values returned to normal one week following cessation of treatment. Medium dose but longer duration (100 mg/day X 7 days) of RU 486 treatment is associated with a higher success rate and less side effects than higher dose therapy administered over a shorter period. There were no predictive indices to determine which subjects would respond successfully. The reason for the failure of the drug in 30% of the subjects on the medium dose is not known at this time.

摘要

相似文献

1
Pregnancy termination with a high and medium dosage regimen of RU 486.
Contraception. 1986 May;33(5):455-61. doi: 10.1016/s0010-7824(86)80004-x.
2
Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).使用孕酮拮抗剂RU 486(米非司酮)终止早期妊娠。
N Engl J Med. 1986 Dec 18;315(25):1565-70. doi: 10.1056/NEJM198612183152501.
3
Termination of very early pregnancy by RU 486--an antiprogestational compound.用RU 486(一种抗孕激素化合物)终止早早孕
Contraception. 1984 May;29(5):399-410. doi: 10.1016/0010-7824(84)90014-3.
4
Induction of abortion in early first trimester human pregnancy using epostane.使用依波斯坦诱导人类妊娠早期头三个月的流产。
Br J Obstet Gynaecol. 1989 Mar;96(3):340-5. doi: 10.1111/j.1471-0528.1989.tb02395.x.
5
The antiprogestational agent RU 486 as an abortifacient in early human pregnancy: a comparison of three dose regimens.抗孕激素药物RU 486作为早期妊娠终止剂:三种剂量方案的比较。
Contraception. 1988 Oct;38(4):391-400. doi: 10.1016/0010-7824(88)90080-7.
6
Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.米非司酮联合前列腺素阴道栓用于早期妊娠治疗性流产的引产
Lancet. 1987 Dec 19;2(8573):1415-8. doi: 10.1016/s0140-6736(87)91126-3.
7
Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.口服前列腺素E2对接受RU 486(米非司酮)终止早期妊娠的妇女子宫收缩力及治疗结局的影响。
Hum Reprod. 1989 Jan;4(1):21-8. doi: 10.1093/oxfordjournals.humrep.a136838.
8
Anti-progesterones for the interruption of pregnancy.用于终止妊娠的抗孕激素。
Baillieres Clin Obstet Gynaecol. 1988 Sep;2(3):617-29. doi: 10.1016/s0950-3552(88)80048-8.
9
[Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
Ann Endocrinol (Paris). 1983;44(5):345-6.
10
Early abortion with a single dose of the antiprogestin RU-486.单次服用抗孕激素RU-486进行早期流产。
Am J Obstet Gynecol. 1988 Jun;158(6 Pt 1):1307-12. doi: 10.1016/0002-9378(88)90361-4.

引用本文的文献

1
Oral medications for central serous chorioretinopathy: a literature review.口服药物治疗中心性浆液性脉络膜视网膜病变:文献综述。
Eye (Lond). 2020 May;34(5):809-824. doi: 10.1038/s41433-019-0568-y. Epub 2019 Sep 16.
2
A benefit-risk assessment of medical treatment for uterine leiomyomas.子宫肌瘤医学治疗的获益-风险评估
Drug Saf. 2002;25(11):759-79. doi: 10.2165/00002018-200225110-00002.